3 unknown, 2 recruiting, 1 completed. 3 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow HDM1002: new trials by email Literature Review of HDM1002 trials Research Report on HDM1002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin Metformin, Empagliflozin, Midazolam - Overweight Subject, Healthy Subjects | Phase 1 | Recruiting | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 111 | 2025-09-24 | 2026-01-09 |
| A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg - Type 2 Diabetes | Phase 3 | Recruiting | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 800 | 2025-07-14 | 2025-07-24 |
| A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects. Repaglinide, Atorvastatin, Digoxin - Healthy Adult Subject, Overweight Subject | Phase 1 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 30 | 2024-10-01 | 2024-09-23 |
| A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects HDM1002 - Healthy Adult Subject | Phase 1 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 33 | 2024-10-01 | 2024-09-23 |
| Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults HDM1002 100 mg QD, HDM1002 200 mg QD 12weeks, HDM1002 400 mg QD 12weeks - Overweight and Obesity | Phase 2 | Unknown | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 180 | 2024-07-15 | 2024-07-15 |
| To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus HDM1002 50 mg, HDM1002 100 mg, HDM1002 200 mg - Type 2 Diabetes | Phase 2 | Completed | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 324 | 2024-06-27 | 2025-07-28 |
Diabetes Mellitus, Type 2 (2) · Obesity (1) · Overweight (1)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (6)
China (5)
Xiaoying Li (1) · Yiming Mu, Ph.D (1)